1. Home
  2. TRML vs BAND Comparison

TRML vs BAND Comparison

Compare TRML & BAND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TRML
  • BAND
  • Stock Information
  • Founded
  • TRML 2021
  • BAND 2000
  • Country
  • TRML United States
  • BAND United States
  • Employees
  • TRML N/A
  • BAND N/A
  • Industry
  • TRML Biotechnology: Pharmaceutical Preparations
  • BAND Computer Software: Prepackaged Software
  • Sector
  • TRML Health Care
  • BAND Technology
  • Exchange
  • TRML Nasdaq
  • BAND Nasdaq
  • Market Cap
  • TRML 509.8M
  • BAND 495.2M
  • IPO Year
  • TRML N/A
  • BAND 2017
  • Fundamental
  • Price
  • TRML $12.21
  • BAND $17.00
  • Analyst Decision
  • TRML Strong Buy
  • BAND Buy
  • Analyst Count
  • TRML 6
  • BAND 8
  • Target Price
  • TRML $54.00
  • BAND $27.43
  • AVG Volume (30 Days)
  • TRML 344.8K
  • BAND 355.6K
  • Earning Date
  • TRML 03-18-2025
  • BAND 02-20-2025
  • Dividend Yield
  • TRML N/A
  • BAND N/A
  • EPS Growth
  • TRML N/A
  • BAND N/A
  • EPS
  • TRML N/A
  • BAND N/A
  • Revenue
  • TRML N/A
  • BAND $748,487,000.00
  • Revenue This Year
  • TRML N/A
  • BAND $25.91
  • Revenue Next Year
  • TRML N/A
  • BAND $3.05
  • P/E Ratio
  • TRML N/A
  • BAND N/A
  • Revenue Growth
  • TRML N/A
  • BAND 24.52
  • 52 Week Low
  • TRML $12.12
  • BAND $11.90
  • 52 Week High
  • TRML $48.31
  • BAND $25.02
  • Technical
  • Relative Strength Index (RSI)
  • TRML 25.27
  • BAND 42.02
  • Support Level
  • TRML $12.13
  • BAND $15.80
  • Resistance Level
  • TRML $14.58
  • BAND $19.88
  • Average True Range (ATR)
  • TRML 0.84
  • BAND 0.89
  • MACD
  • TRML -0.05
  • BAND -0.10
  • Stochastic Oscillator
  • TRML 1.79
  • BAND 29.41

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

About BAND Bandwidth Inc.

Bandwidth Inc is cloud-based communications platform-as-a-service (CPaaS) provider that enables enterprises to create, scale and operate voice or messaging communications services across any mobile application or connected device. Company earns revenue through the sale of communications services offered through Application Programming Interface software solutions to large as well as small and medium-sized business, customers and is generally derived from usage and service fees. Usage revenue includes voice communication (driven by inbound and outbound minutes and toll-free minutes) and messaging communication (driven by the number of messages) that traverse the platform and network. Service fees include the provision and management of phone numbers and emergency services access.

Share on Social Networks: